 Function GO Term   transferase activity    And related genes <body> Function GO Term transferase activity  and related genes   Total 510 
Page number 5 * 	  Previous Page   *  Next Page    1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   18  
    Gene Name  ORF Name   Function GO Term   Process GO Term  Component GO Term  Interacting Genes  Description  Gene Product  Phenotype     ECM40   YMR062C   amino-acid N-acetyltransferase activity*   cell wall organization and biogenesis*  mitochondrial matrix    ExtraCellular Mutant  acetylornithine acetyltransferase  A Tn3 insertion into this gene causes hypersensitivity to the cell surface polymer perturbing agent     ECO1   YFR027W   acetyltransferase activity   DNA repair*  nuclear chromatin  YHR114W	  Establishment of COhesion    Null mutant is inviable; temperature-sensitive allele prematurely separates sister chromatids, and s     EKI1   YDR147W   choline kinase activity*   phosphatidylethanolamine biosynthesis  cellular_component unknown    Ethanolamine Kinase 1  ethanolamine kinase  Null mutant is viable     ELM1   YKL048C   protein kinase activity*   protein amino acid phosphorylation*  contractile ring (sensu Saccharomyces)  YDL185W	YJR113C	YBR160W	YJR090C	YNL271C	YFL037W	YER016W	YOR058C	YOR326W	YEL061C	YMR078C	YLR200W	YGR078C	YNL153C	YEL003W	YML094W	YLR342W	YGR229C	  cell morphology  protein kinase  formation of expanded, branched chains of elongated cells; grow invasively under the surface of agar     ELO1   YJL196C   fatty acid elongase activity   fatty acid elongation, unsaturated fatty acid  membrane  YNL192W	  Elongase I extends C12-C16 fatty acyl-CoAs to C16-C18 fatty acids  elongase  Null mutant is viable, but shows no growth on media supplemented with less than 16-C saturated fatty     EPL1   YFL024C   histone acetyltransferase activity   regulation of transcription from Pol II promoter*  histone acetyltransferase complex  YFL039C	YHR099W	YDR359C	YNL030W	YPR023C	YOR244W	YNL107W	YEL018W	YJL098W	  Enhancer of Polycomb-Like (from  D. melanogaster ).  Subunit of the Nucleosomal Acetyltransfera  NuA4 histone acetyltransferase complex component  Null mutant is inviable.     EPT1   YHR123W   ethanolaminephosphotransferase activity   phosphatidylethanolamine biosynthesis  endoplasmic reticulum  YIR038C	YEL017W	YBR038W	  sn-1,2-diacylglycerol ethanolamine- and cholinephosphotranferase  sn-1,2-diacylglycerol ethanolamine- and cholinephosphotranferase  Null mutant is viable     ERF2   YLR246W   palmitoyltransferase activity   protein-membrane targeting*  integral to endoplasmic reticulum membrane  YJR146W	  Mutation has an Effect on Ras Function. Implicated in signaling pathway.    Null mutant is viable, but has a synthetic growth defect in the absence of RAS2; Deletion of ERF2 re     ERG10   YPL028W   acetyl-CoA C-acetyltransferase activity   ergosterol biosynthesis  cytosol  YPR165W	YGR223C	YNL244C	YPL026C	YBR055C	  induced under stress conditions  acetoacetyl CoA thiolase  Nul mutant is inviable; other mutants are ergosterol biosynthesis defective or nystatin resistant     ERG12   YMR208W   mevalonate kinase activity   ergosterol biosynthesis  cytosol    mevalonate catabolism  mevalonate kinase  Null mutant is inviable and unable to grow vegetatively or germinate spores; mutants exhibit increas     ERG13   YML126C   hydroxymethylglutaryl-CoA synthase activity   ergosterol biosynthesis  mitochondrion*  YNL119W	YFL039C	YIL094C	YLR180W	YKL125W	YDL188C	YJR091C	YMR059W	  involved in mevalonate synthesis  3-hydroxy-3-methylglutaryl coenzyme A synthase       ERG20   YJL167W   dimethylallyltranstransferase activity*   ergosterol biosynthesis*  cytosol  YDL186W	YNL244C	YJR035W	YBR055C	YPL149W	YDR369C	  May be rate-limiting step in sterol biosynthesis pathway  farnesyl diphosphate synthetase (FPP synthetase)  Null mutant is inviable     ERG6   YML008C   sterol 24-C-methyltransferase activity   ergosterol biosynthesis  endoplasmic reticulum*  YCL023C	YDL089W	YHR114W	YOR097C	YPL020C	YPR113W	YMR059W	  ergosterol synthesis    The null mutant is viable, cannot methylate ergosterol precursors at C-24, and lacks ergosterol. The     ERG8   YMR220W   phosphomevalonate kinase activity   ergosterol biosynthesis*  cytosol    Involved in isoprene and ergosterol biosynthesis pathways  48 kDa phosphomevalonate kinase  Null mutant is inviable     ERG9   YHR190W   farnesyl-diphosphate farnesyltransferase activity   ergosterol biosynthesis  endoplasmic reticulum  YIR038C	YMR153W	YLR453C	  squalene synthetase  squalene synthetase  Null mutant is inviable     ESA1   YOR244W   histone acetyltransferase activity   regulation of transcription from Pol II promoter*  histone acetyltransferase complex  YKR021W	YFL039C	YHR099W	YOL086C	YML007W	YDR359C	YPR023C	YNL107W	YJL081C	YFL024C	YDR271C	YJL098W	  contains amino-terminal chromodomains; Essential SAS family Acetyltransferase sharing homology with  NuA4 complex component|acetyltransferase in the SAS gene family  Null mutant is inviable     EST2   YLR318W   telomeric template RNA reverse transcriptase activity   telomerase-dependent telomere maintenance  nucleus*  YLR039C	YLR262C	YLR085C	  Contributes to the catalytic activity of telomerase and to other aspects of telomerase assembly and  telomerase reverse transcriptase  Null mutant is viable, exhibits progressively shorter telomeres, cellular senescence and a telomeras     EST3   YIL009C-A   telomerase activity   telomerase-dependent telomere maintenance  nucleus*  YML092C	  ever shorter telomeres  20.5 kDa 181aa protein  Null mutant shows progressively shorter telomeres and cellular senescence; telomerase activity is st     ETR1   YBR026C   enoyl-acyl-carrier protein reductase activity   aerobic respiration*  mitochondrion    Involved in mitochondrial fatty acid biosynthesis  2-enoyl thioester reductase, E.C. 1.3.1.-  Null mutant is viable but is respiratory-deficient     FAB1   YFR019W   1-phosphatidylinositol-3-phosphate 5-kinase activity   response to stress*  vacuolar membrane  YOL135C	YDL047W	YNL271C	YDR162C	YER016W	YNL298W	YOR269W	YDR150W	YCL029C	YOR326W	YLR200W	YGR078C	YNL153C	YEL003W	YML094W	YLR103C	YBR023C	YLR330W	YBL061C	YNL322C	  May regulate vacuole homeostasis. Catalyzes formation of phosphatidylinositol-3,5-bisphosphate via p  1-phosphatidylinositol-3-phosphate 5-kinase  Null mutant is temperature-sensitive. Mutation causes pleiotropic effects on nuclear migration and o     FAD1   YDL045C   FMN adenylyltransferase activity   FAD biosynthesis  cytoplasm  YGL127C	YLR295C	  Flavin adenine dinucleotide (FAD) synthetase, which performs second step in synthesis of FAD from ri  FAD synthetase  Null mutant is inviable     FEN1   YCR034W   fatty acid elongase activity   sphingolipid biosynthesis*  endoplasmic reticulum*  YMR202W	YLR372W	YOR049C	YCR009C	YDL017W	YLR342W	  Elongase II elongates palmitoyl-CoA and stearoyl-CoA up to C22 fatty acids, and is also involved in  1,3-beta-glucan synthase subunit (putative) ELO1 homolog  Null mutant is viable; slow growth; fenpropimorph resistant; resistant to a pneumocandin B0 analog (     FMN1   YDR236C   riboflavin kinase activity*   FMN biosynthesis  mitochondrial inner membrane*  YDR398W	  Riboflavin kinase  riboflavin kinase       FMT1   YBL013W   methionyl-tRNA formyltransferase activity   translational initiation*  mitochondrion    Formyl-Methionyl-tRNA Transformylase (consistent with name of bacterial homologs)  methionyl-tRNA transformylase  Null mutant is viable and lacks mitochondrial formyl-Met-tRNA     FOL1   YNL256W   2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity*   folic acid and derivative biosynthesis  cytoplasm    folic acid synthesis  dihydro-6-hydroxymethylpterin pyrophosphokinase|dihydroneopterin aldolase|dihydropteroate synthetase  essential, induces pseudohyphal growth     FUR1   YHR128W   uracil phosphoribosyltransferase activity   pyrimidine salvage  cellular_component unknown  YNR012W	YDL100C	YHR152W	YPR185W	YLR056W	YLR295C	YFR028C	  Regulation of the pyrimidine salvage pathway  UPRTase  Null mutant is viable, resistant to 5-FU     GAL1   YBR020W   galactokinase activity   galactose metabolism  cellular_component unknown  YML051W	YER081W	  galactokinase  galactokinase  Null mutant is viable and cannot utilize galactose.     GAL7   YBR018C   UTP-hexose-1-phosphate uridylyltransferase activity   galactose metabolism  cytoplasm  YER081W	YNL161W	YKL108W	YPR054W	YHR030C	YGL137W	YMR106C	  galactose-1-phosphate uridyl transferase  galactose-1-phosphate uridyl transferase  Null mutant is viable and cannot utilize galactose.     GAL83   YER027C   SNF1A/AMP-activated protein kinase activity   protein amino acid phosphorylation*  nucleus  YGL115W	YOR276W	YGL208W	YDR206W	YDR477W	  Glucose repression protein    Null mutant is viable     GCD10   YNL062C   tRNA methyltransferase activity   translational initiation*  nucleus  YOR361C	YJL125C	YPR086W	  First identified as negative regulator of GCN4 expression  RNA-binding protein|subunit of tRNA(1-methyladenosine) methyltransferase, along with Gcd14p  Null mutant is inviable. There are mutants available that show constitutive HIS4 transcription and s   </body> 